Exploring the patient perceived impact of non-alcoholic steatohepatitis
Doward, L.C, Balp, M.-M, Stewart, K.E, Cryer, D, Langford, A, Twiss, J, Agashivala, N, Brass, C.A, Anstee, Q.M, Sanyal, A
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
P764 ANALYSIS OF THE EFFECT OF CYCLOPHILIN INHIBITOR ALISPORIVIR ON THE INTERFERON RESPONSE IN HCV-INFECTED CELLS AND PATIENTS
Bobardt, M, Baugh, J, Gallay, P, Ma, S, Kaiser, S, Hartmann, N, Letzkus, M, Staedtler, F, Riva, A, Chokshi, S, Nirmala, N.R, Johnson, K.J, Brass, C.A, Naoumov, N.V, Li, B
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
7 BOCEPREVIR IN ADDITION TO STANDARD OF CARE ENHANCED SVR IN HEPATITIS C VIRUS (HCV) GENOTYPE-1 WITH ADVANCED FIBROSIS/CIRRHOSIS: SUBGROUP ANALYSIS OF SPRINT-2 AND RESPOND-2 STUDIES
Bruno, S, Vierling, J.M, Esteban, R, Nyberg, L.M, Tanno, H, Albrecht, J.K, Brass, C.A, Boparai, N, Sniukiene, V, Burroughs, M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
422 PROJECTING THE CLINICAL IMPACT OF THERAPEUTIC REGIMENS INCLUDING BOCEPREVIR IN PREVIOUSLY UNTREATED ADULT SUBJECTS WITH CHRONIC HEPATITIS C GENOTYPE 1
Ferrante, S, Chhatwal, J, Dasbach, E.J, El Khoury, A, Sniukiene, V, Poordad, F.F, Bronowicki, J.-P, Brass, C.A
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
452 EFFICACY AMONG NORTH AMERICAN AND EUROPEAN HCV GENOTYPE-1 TREATMENT-NAIVE AND PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
Marcellin, P, Vierling, J.M, Alric, L, Pirisi, M, Tran, A, Albrecht, J.K, Brass, C.A, Boparai, N, Sniukiene, V, Burroughs, M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
449 OVERALL SAFETY PROFILE OF BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
Manns, M.P, Felizarta, F, Schiff, E, Burroughs, M, Sniukiene, V, Boparai, N, Brass, C.A, Albrecht, J.K, Vierling, J.M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
12 IL28B POLYMORPHISM PREDICTS VIROLOGIC RESPONSE IN PATIENTS WITH HEPATITIS C GENOTYPE 1 TREATED WITH BOCEPREVIR (BOC) COMBINATION THERAPY
Poordad, F, Bronowicki, J.-P, Gordon, S.C, Zeuzem, S, Jacobson, I.M, Sulkowski, M.S, Poynard, T, Morgan, T.R, Burroughs, M, Sniukiene, V, Boparai, N, Brass, C.A, Albrecht, J.K, Bacon, B.R
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
466 PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 WHEN TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN (PR)
Reddy, K.R, Bruno, S, Rossaro, L, Ravendhran, N, Pauly, M.P, Boparai, N, Sniukiene, V, Brass, C.A, Albrecht, J.K, Poordad, F, Jacobson, I.M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
9 BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS (RAVS) ARE OBSERVED MORE FREQUENTLY IN HCV (GT1)-INFECTED PATIENTS WITH POOR RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRIN
Zeuzem, S, Barnard, R.J, Howe, J.A, Ogert, R.A, Ralston, R, Boparai, N, Brass, C.A, Albrecht, J.K, Burroughs, M, Sniukiene, V, Poordad, F, Gordon, S.C, Jacobson, I.M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
428 ADHERENCE TO ASSIGNED DOSING REGIMEN AND SUSTAINED VIROLOGIC RESPONSE AMONG HEPATITIS C GENOTYPE 1 TREATMENT-NAIVE AND PEG/RIBAVIRIN TREATMENT-FAILURES TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
Gordon, S.C, Lawitz, E.J, Bacon, B.R, Sulkowski, M.S, Yoshida, E.M, Davis, M, Boparai, N, Sniukiene, V, Burroughs, M, Brass, C.A, Albrecht, J.K, Reddy, K.R
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
478 INFECTIONS DURING PEGINTERFERON (PEGIFN)/RIBAVIRIN (RBV) THERAPY ARE ASSOCIATED WITH THE MAGNITUDE OF DECLINE IN THE LYMPHOCYTE COUNT: RESULTS OF THE IDEAL STUDY
Melia, M, Brau, N, Poordad, F, Lawitz, E.J, Shiffman, M, McHutchison, J, Muir, A, Galler, G, McCone, J, Nyberg, L, Lee, W, Ghalib, R, Schiff, E, Long, J, Noviello, S, Brass, C.A, Pedicone, L.D, Albrecht, J, Sulkowski, M.S
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
304 METABOLIC SYNDROME (MS) IS A NEGATIVE PREDICTOR OF TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE IDEAL STUDY
Sulkowski, M.S, King, J.W, Harrison, S.A, Rossaro, L, Hu, K.-Q, Lawitz, E.J, Schiffman, M.L, Muir, A.J, Galler, G.W, McCone, J, Nyberg, L.M, Lee, W.M, Ghalib, R, McHutchison, J.G, Noviello, S, Goteti, V.S, Albrecht, J.K, Brass, C.A
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
413 FIBROTEST (FT) VALUE INDEPENDENTLY PREDICTS EARLY (EVR) AND SUSTAINED VIROLOGICAL RESPONSE (SVR) IN NON-RESPONDER PATIENTS RE-TREATED WITH PEGYLATED INTERFERON ALFA-2B (PEG-2B) AND RIBAVIRIN IN EPIC3
Poynard, T, Schiff, E.R, Terg, R, Moreno-Otero, R, Flamm, S.L, Schmidt, W, Berg, T, Goncales, F.L, Heathcote, J.E, Diago, M, McGarrity, T, Bedossa, P, Zhou, H, Mukhopadhyay, P, Griffel, L.H, Burroughs, M, Brass, C.A, Albrecht, J.K
Published in Journal of hepatology (01.04.2009)
Published in Journal of hepatology (01.04.2009)
Get full text
Journal Article
49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL
Bruix, J, Poynard, T, Colombo, M, Schiff, E, Reichen, J, Burak, K, Heathcote, E.J.L, Berg, T, Poo-Ramirez, J.-L, Mello, C. Brandao, Guenther, R, Niederau, C, Terg, R, Bopari, N, Harvey, J, Griffel, L.H, Burroughs, M, Brass, C.A, Albrecht, J.K
Published in Journal of hepatology (01.04.2009)
Published in Journal of hepatology (01.04.2009)
Get full text
Journal Article
433 FREQUENCIES OF RESISTANCE-ASSOCIATED AMINO ACID VARIANTS DETECTED BY 454-SEQUENCING DURING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEGINTRON (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN HCV (GT1)-INFECTED PATIENTS
Howe, J.A, Qiu, P, Ogert, R.A, Mendez, P, Brass, C.A, Albrecht, J, Ralston, R, Barnard, R.J.O, Hazuda, D
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
484 PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
Zeuzem, S, Vierling, J.M, Esteban, R, Gibas, A.L, Pol, S, Boparai, N, Burroughs, M, Brass, C.A, Albrecht, J.K, Poordad, F
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
1419 A RANDOMIZED TRIAL COMPARING RIBAVIRIN DOSE REDUCTION VERSUS ERYTHROPOIETIN FOR ANEMIA MANAGEMENT IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS C RECEIVING BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN
Poordad, F.F, Lawitz, E.J, Reddy, K.R, Afdhal, N.H, Hezode, C, Zeuzem, S, Lee, S.S, Calleja, J.L, Brown, R.S, Craxi, A, Wedemeyer, H, Deng, W, Koury, K, Boparai, N, Pedicone, L.D, Burroughs, M, Wahl, J, Brass, C.A, Albrecht, J.K, Sulkowski, M.S
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1
Manns, M.P, Poordad, F, Bacon, B.R, Bruno, S, Esteban, R, Silva, M, Buti, M, Burroughs, M, Sniukiene, V, Boparai, N, Brass, C.A, Albrecht, J.K, Bronowicki, J.-P
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
476 ANEMIA DURING TREATMENT WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN WITH OR WITHOUT BOCEPREVIR IS ASSOCIATED WITH HIGHER SVR RATES: ANALYSIS OF PREVIOUSLY UNTREATED AND PREVIOUS-TREATMENT-FAILURE PATIENTS
Sulkowski, M.S, Poordad, F, Manns, M.P, Bronowicki, J.-P, Reddy, K.R, Harrison, S.A, Afdhal, N.H, Boparai, N, Sniukiene, V, Burroughs, M, Albrecht, J.K, Brass, C.A, Jacobson, I.M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
481 FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
Vierling, J.M, Lawitz, E.J, Poordad, F, Sulkowski, M.S, Bourliere, M, Buti, M, Cooper, C, Galati, J.S, Albrecht, J.K, Boparai, N, Brass, C.A, Burroughs, M, Sniukiene, V, Bruno, S
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article